ArticleCancer immunology research2023

Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.

Renee Maria Saliby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.